Document Type : 6th congress of endocrinology & metabolism
Authors
1
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2
Department of Biotechnology, Faculty of Biological Sciences, Falavarjan Branch, Islamic Azad University, Isfahan
10.48305/jims.v43.i827.0972
Abstract
Background: With approximately 589 million people worldwide affected by diabetes, achieving therapeutic goals remains challenging despite advances in medical treatments and technology. Pharmacotherapy alone is insufficient for optimal diabetes control, emphasizing the need for behavioral optimization and psychosocial support. Telehealth DSMES offers a scalable, patient-centered solution by integrating digital tools to deliver core DSMES components remotely. This approach addresses critical gaps in traditional DSMES, such as limited access to educators, geographic barriers, and time constraints. Telehealth DSMES enables tailored education on pathophysiology, insulin injection techniques, oral medication management (dosing, timing, and administration), blood glucose monitoring, complication prevention, and problem-solving skills through virtual platforms, ensuring sustained engagement and empowerment.
Telehealth DSMES programs deliver evidence-based content via remote platforms, including.
Programs are personalized to cultural, linguistic, and literacy needs, leveraging interprofessional teams (endocrinologists, dietitians, diabetes educators) during critical junctures: at diagnosis, annually or when treatment goals are unmet, during complicating factors (e.g., CKD, stroke), and during transitions in care. Outcomes are measured via HbA1c reductions, quality-of-life metrics, and healthcare utilization rates.
Clinical trials demonstrate that Telehealth DSMES reduces HbA1c by ≥0.6% over 6–12 months, comparable to in-person DSMES. Key advantages include: Improved Access, Cost-Effectiveness, Psychosocial Benefits, and Scalability.
Conclusion: Telehealth DSMES represents a paradigm shift in diabetes management, combining clinical rigor with digital innovation. To maximize impact, healthcare systems must:
1. Prioritize Telehealth DSMES: Integrate it into national diabetes care guidelines.
2. Invest in Infrastructure: Expand broadband access and digital literacy training for patients and providers.
3. Develop Hybrid Models: Combine telehealth with in-person follow-ups for complex cases (e.g., insulin pump users).
4. Policy Reforms: Reimburse virtual DSMES sessions and incentivize provider participation.
By adopting Telehealth DSMES, stakeholders can reduce the global diabetes burden, empower patients, and achieve equitable, high-quality care.
Highlights
Mojtaba Akbari: PubMed ,Google Scholar
Keywords
Main Subjects
)